Stock Market Analysis Video 4/30/2010

The stock charts used in this presentation are provided by WONDA ® Copyright © 2016 William O’Neil + Co., Inc. All rights reserved. Unauthorized duplication, modification, photocopying or distribution in any form is strictly prohibited.

Editor Paul Goodwin looks at the volitile action of some big name stocks, including Baidu (BIDU), Green Mountain Coffee Roasters (GMCR), Yum! Brands (YUM), Dr. Reddy's Laboratories (RDY), America Movil (AMX), Mobile TeleSystems (MBT).

Paul Goodwin Paul Goodwin
Emerging Markets Specialist, Analyst and Editor of Cabot China & Emerging Markets Report

A researcher and writer for over 30 years, Paul Goodwin has been a member of the Cabot investment team and editor of Cabot China & Emerging Markets Report since 2005. Under Paul’s stewardship, Hulbert Financial Digest rated Cabot China & Emerging Markets Report  the number-one-rated newsletter of 2006 with a 78.6% gain for the year, the number-one-rated newsletter of 2007 with a  74.1% return, and is currently the top-performing investment adivsory for five years with a 17.7% annualized return as of 2/28/10. Cabot China & Emerging Markets Report was also named 2007 Investment Letter of the Year by Peter Brimelow of MarketWatch.


And now a word from : Timothy Lutts, Cabot President and Chief Investment Strategist



Dear Reader,

We're popping champagne corks after learning that Cabot China & Emerging Markets Report has once again been named the top-performing investment newsletter of the past five years, with a compound annual gain of 21.4% as of December 31, 2009.

Cabot China & Emerging Markets Report is rewarding its subscribers with a 164% total return over the past five years (an average annualized gain of 21.4% every year), compared to the S&P 500's increase of a mere 2.1% (dividends included) over the same period.

I'm very proud of our achievement—for the whole Cabot team—but I'm kind of sad that so many investors are still stuck in underperforming broad-based U.S. investments ...

... while emerging markets stocks continue to make fortunes for investors with the courage and intelligence to venture out there.

So I'm going to do two things here.

First, I'm going to explain how Cabot China & Emerging Markets Report racked up this first place performance.

And second, I'm going to tell you how you can join our subscribers and profit from the fastest-growing major economies in the world.

The story begins back in 2004, when I noticed that an increasing number of Chinese stocks were performing well.

Upon investigation, I found the main reason was simple.

The Chinese economy was booming ... and there was a shortage of supply of Chinese stocks to invest in.

Putting two and two together, I figured it was a trend with the potential to last a long while, so I began publishing a newsletter called Cabot China & Emerging Markets Report.

And I instructed the editor, Paul Goodwin, to adhere to the time-tested Cabot growth investing system that has now served us for 39 years.

What this means, simply, is this:

He pays attention to charts, favoring stocks with strong momentum.

He pays attention to fundamentals, favoring young companies with good current growth and the promise of much more ahead. In China, which is growing so fast, great growth opportunities are pretty much everywhere.

And he pays attention to market timing ... which means his subscribers preserved profits last year by sitting in cash while most investors were watching their portfolios melt away.

The results have been gratifying, to say the least.

Moreover, the outperformance continues—in fact, while many U.S. stocks have been doing well in the bull move since March, Chinese stocks are still the undisputed leaders of the advance! Many more exciting young Chinese firms are being listed here on U.S. stock exchanges each month, and institutional investors have been piling in, eager to invest money in the biggest growth area in the world.

And if your goal is profits, I sincerely think you should consider joining them!

So, if you're ready to apply the lessons of a time-tested investment strategy ...

If you're ready to invest in the leading stocks of China ...

And if you're ready to take advice from the leading expert in the field, I invite you to join Paul's happy subscribers by taking a trial subscription to Cabot China & Emerging Markets Report.

Give it a try today. With my money-back guarantee, you've got nothing to lose and everything to gain!

Order Now  Learn More


Best wishes with all of your investments,

Timothy Lutts

Timothy Lutts
Publisher

P.S.  A lot of people are still wondering whether this bull market is for real. I firmly believe it is, for the many reasons I've spelled out here in recent weeks, and I urge you not to delay investing any longer. Join Paul Goodwin's very satisfied Cabot China & Emerging Markets Report subscribers today.

Headline News

Stock Picks

Loews Corp.

This undervalued stock has strong future earnings growth expectations.

Biogen

Biogen is the market-share leader in treating multiple sclerosis.

Weibo

One of Paul Godwin’s favorite stocks in his Cabot Emerging Markets Investor portfolio.

Cabot Wealth Advisory

Does Alibaba (BABA) Stock Measure Up to Amazon (AMZN)?

By Paul Goodwin on September 23, 2016

Alibaba (BABA) is the Amazon (AMZN) of China. But does BABA stock measure up to AMZN stock? Let’s break it down!Read More >

As Stock Market Trends Change, Invest in these New Leaders

By Michael Cintolo on September 22, 2016

History tells us that all stock market trends change, and if you don’t recognize the leaders of that change early, you risk missing out on the next big winners.Read More >

AMZN Stock vs. FB Stock: Which Is the Better Value Buy?

By J. Royden Ward on September 20, 2016

For the past five years, AMZN stock and FB stock have been two of the market's great growth stories. But could you make the case that either stock is still undervalued? Let’s break it down.Read More >